1-12 of 12
Andrew Roberts
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Open Access, 20 Years Later

Nancy Berliner, MD, Andrew Roberts, MD
Journal: The Hematologist
The Hematologist (2023) 20 (5)
https://doi.org/10.1182/hem.V20.5.2023516
Published: 2023
Articles

Deciphering the Dilemmas Posed by Detection of Mutant Myeloid Clones

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2018) 16 (1)
https://doi.org/10.1182/hem.V16.1.9299
Published: 2018
Articles

Acquired Clinical Resistance to IDH2 Inhibitors: Leukemia Finds Multiple Avenues for Escape

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2018) 15 (6)
https://doi.org/10.1182/hem.V15.6.9020
Published: 2018
Articles

Not All Large Cells Are Created Equal: Is Genomic Classification the New Frontier in Diffuse Large B-cell Lymphoma?

Costas K. Yannakou, MBBS (Hons), FRACP, FRCPA, Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2018) 15 (5)
https://doi.org/10.1182/hem.V15.5.8883
Published: 2018
Articles

Targeted Therapy to Trigger GVL: A Case for the Prosecution in FLT3-ITD–Mutant AML

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2018) 15 (3)
https://doi.org/10.1182/hem.V15.3.8469
Published: 2018
Articles

Complexity of DNA Repair From Alcohol Damage Revealed

Edward Chew, MBBS, Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2018) 15 (2)
https://doi.org/10.1182/hem.V15.2.8291
Published: 2018
Articles

Lighting the Path to Personalized Medicine for Hematologic Malignancies: Lessons From an AML Knowledge Bank

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2017) 15 (1)
https://doi.org/10.1182/hem.V15.1.8121
Published: 2017
Articles

A Randomized Trial in a Rare Cancer: Targeting CD30 in Cutaneous T Cell Lymphoma Yields Therapeutic Dividends

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2017) 14 (6)
https://doi.org/10.1182/hem.V14.6.7793
Published: 2017
Articles

CHIP and Coronary Heart Disease: Clonal Hematopoiesis Increases Atherosclerosis

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2017) 14 (5)
https://doi.org/10.1182/hem.V14.5.7618
Published: 2017
Articles

Can Chemoimmunotherapy Be Improved As Front-Line Therapy for CLL in Fit Patients?

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2017) 14 (4)
https://doi.org/10.1182/hem.V14.4.7473
Published: 2017
Articles

Stopping Imatinib in CML: Safe in the Long Term for Deep Molecular Responders As the Immune System Steps Up

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2017) 14 (3)
https://doi.org/10.1182/hem.V14.3.7261
Published: 2017
Articles

Relapsed CLL: A Problem, Not Yet Solved

Andrew Roberts, MBBS, PhD, FRACP, FRCPA
Journal: The Hematologist
The Hematologist (2017) 14 (2)
https://doi.org/10.1182/hem.V14.2.7136
Published: 2017